How to use AlphaBind Antibody-Antigen Affinity Prediction Online

Fine-tune AlphaBind on target-specific binding measurements, then rank antibody candidates against the same antigen.

AlphaBind is a sequence-based antibody-antigen affinity model designed for supervised antibody optimization. It combines residue embeddings from NVIDIA's ESM-2nv 3B protein language model with a transformer affinity regressor pretrained on approximately 7.5 million quantitative antibody-antigen measurements.

Published evaluation shows that the public checkpoint is not a generally reliable zero-shot affinity predictor: correlations were absent for three evaluated parental antibodies and modest for VHH72. Neurosnap therefore requires target-specific fine-tuning data instead of presenting pretrained scores as calibrated affinity predictions. Researchers upload measured antibody-antigen pairs, fine-tune the public checkpoint, and then rank related candidates against the same antigen.

How AlphaBind Antibody-Antigen Affinity Prediction Works

Prepare Fine-Tuning Dataset as a CSV with the case-sensitive columns sequence_a, sequence_alpha, and Kd. Each row must contain one unique antibody-antigen pair, every sequence_alpha must exactly match the submitted Antigen Sequence, and at least ten measured rows are required to form a training-validation split. More numerous, diverse, and assay-consistent measurements generally provide a more defensible model. Candidate sequences should use the same construct format and remain close to the sequence domain represented in training.

Set Training Target Scale to log10(KD nM) only when the CSV values are log10-transformed dissociation constants in nanomolar units. In that mode, lower predictions indicate tighter binding and Neurosnap also reports the corresponding KD estimate. Use Custom Lower-Is-Better Score for enrichment or another proxy assay; those outputs remain assay-scale scores and are not converted into KD.

Neurosnap computes ESM-2nv embeddings, fine-tunes the published AlphaBind checkpoint, selects the checkpoint with the best validation loss, and scores up to 64 candidates. It returns the ranked predictions, raw training metrics, and the fine-tuned model. Each antibody-antigen pair is limited to 600 total residues. Predictions remain computational estimates and should be checked with held-out experimental data before design decisions.

What is Neurosnap?

Neurosnap is the leading platform for bioinformatics and computational science focused on expanding access to powerful modeling and simulation tools. Because many state-of-the-art machine learning systems remain complex to install, configure, and scale, Neurosnap offers a clean, browser-based workspace that removes the burden of infrastructure management, dependency conflicts, and command-line tooling.

Built for biologists, chemists, and cross-disciplinary scientists, the platform enables advanced computational workflows without requiring expertise in software engineering or cloud architecture. Researchers can launch analyses through an intuitive interface, connect programmatically through a comprehensive API, and rely on automated resource management to scale workloads efficiently. By taking care of the underlying compute and operational complexity, Neurosnap allows teams to devote their energy to scientific progress and faster iteration. Security and data protection remain foundational principles, with clear safeguards outlined in our Terms of Use and Privacy Policy to ensure your work stays protected.

Advancing Discovery with AlphaBind Antibody-Antigen Affinity Prediction on Neurosnap

Using AlphaBind Antibody-Antigen Affinity Prediction on Neurosnap could drastically accelerate target-specific AlphaBind fine-tuning and sequence-based antibody candidate ranking.

Supervised target adaptation: Uploaded measurements tune AlphaBind to the antigen and assay represented by the user's experiment.
Honest score semantics: Physical log10 KD labels and custom proxy scores are kept distinct in the outputs.
Reusable model artifact: The fine-tuned model and training metrics are returned alongside ranked candidate predictions.
No structure required: AlphaBind operates from antibody and antigen sequences, avoiding a separate complex-prediction step for early triage.

How to Use AlphaBind Antibody-Antigen Affinity Prediction on Neurosnap

To harness the capabilities of AlphaBind Antibody-Antigen Affinity Prediction, researchers can follow this streamlined workflow within Neurosnap:

Access Neurosnap: Start by logging in to the Neurosnap website.
Select Tool: From the list of available tools, choose AlphaBind Antibody-Antigen Affinity Prediction.
Provide Inputs: Provide all the inputs specified within the submission panel and optionally configure the tool as desired.
Run Tool: Submit the AlphaBind Antibody-Antigen Affinity Prediction job and Neurosnap will execute it in the cloud, automatically notifying you as soon as your results are ready.
Review Output: Explore your results through rich visualizations, including figures, plots, and interactive views designed to help you analyze findings with clarity and confidence.

Citations

Please cite the original work when using AlphaBind Antibody-Antigen Affinity Prediction in publications or research outputs.

Agarwal AA, Harrang J, Noble D, McGowan KL, Lange AW, Engelhart E, et al. AlphaBind, a domain-specific model to predict and optimize antibody-antigen binding affinity. mAbs. 2025;17(1):2534626. https://doi.org/10.1080/19420862.2025.2534626

Neurosnap Inc. (2022). Neurosnap: An online platform for computational biology and chemistry. Available at: https://neurosnap.ai/

Similar Services

Explore related tools that support similar research workflows:

BindFilter

ImaPEp Antibody-Antigen Binding Prediction

NeuroBind

ProteinMPNN-ddG

Proudly supporting 50,000+ scientists worldwide, including 7,000+ leading biotech and global biopharma organizations.